Revolution Medicines's chart data is dated 2026-10-08. There is no active technical signal. There are 14 published signal records.
Revolution Medicines last closed at $188.12 (-6.35%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -22.4×. Its overall grade ranks 296 of 738 stocks in Healthcare.
About this company
Revolution Medicines last closed at $188.12 (-6.35%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 296/738
Valuation grade A
Related stocks
- AmgenCompetitor
RAS/MAPK 계열 항암제 개발에서 경쟁
- Mirati TherapeuticsCompetitor
KRAS 표적 항암제 개발 경쟁(현재 BMS에 인수됨)
- Bristol-Myers SquibbCompetitor
고형암·표적항암제 파이프라인에서 직접 경쟁
ETFs holding this stock
Invesco DWA Healthcare Momentum ETF · VanEck Biotech ETF · iShares Genomics Immunology and Healthcare ETF
Details →About Revolution Medicines
- What technical signals does Revolution Medicines (RVMD) have?
- Revolution Medicines current technical signals: no active technical signal.
- Is Revolution Medicines a cup-and-handle pattern?
- No. Revolution Medicines has no valid Cup signal right now.
- What published figures are available for Revolution Medicines?
- Market cap: $36.37B. Trailing 12 months PER: -22.4×. Latest quarter PBR: 15.22×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Revolution Medicines, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.